Full Press Release Details
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team will present at two upcoming investor conferences as follows:
EVENT:H.C. Wainwright 27th Annual Global Investment ConferenceDATE:Monday, September 8, 2025TIME:9:00am ET
EVENT:Morgan Stanley 23rd Annual Global Healthcare ConferenceDATE:Tuesday, September 9, 2025TIME:1:50pm ET
The live and archived webcasts will be accessible from the Company’s website atwww.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visitwww.anipharmaceuticals.com.
Investor Relations:Lisa M. Wilson, In-Site Communications, Inc.T: 212-452-2793E:lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.